Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Babcock & Wilcox Enterprises (BW) Asset Writedowns and Impairment (2017 - 2025)

Babcock & Wilcox Enterprises (BW) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with -$587000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment fell 110.12% year-over-year to -$587000.0, compared with a TTM value of $10.6 million through Sep 2025, down 83.07%, and an annual FY2024 reading of $9.6 million, down 83.08% over the prior year.
  • Asset Writedowns and Impairment was -$587000.0 for Q3 2025 at Babcock & Wilcox Enterprises, down from $632000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $56.6 million in Q4 2023 and bottomed at -$699000.0 in Q2 2024.
  • Average Asset Writedowns and Impairment over 3 years is $10.5 million, with a median of $1.1 million recorded in 2024.
  • Peak annual rise in Asset Writedowns and Impairment hit 44.95% in 2025, while the deepest fall reached 110.12% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $56.6 million in 2023, then plummeted by 81.27% to $10.6 million in 2024, then crashed by 105.54% to -$587000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for BW at -$587000.0 in Q3 2025, $632000.0 in Q1 2025, and $10.6 million in Q4 2024.